A Study to Assess Safety, Tolerability, and Pharmacokinetics of AZD0186
Status:
Recruiting
Trial end date:
2023-07-14
Target enrollment:
Participant gender:
Summary
This study will assess the safety, tolerability, and pharmacokinetics of AZD0186 following
single ascending doses (SAD) via oral administration in healthy adult participants.